Product Description
Product Name: Ledipasvir 90 mg + Sofosbuvir 400 mg Tablets
Form: Oral Tablet
Therapeutic Class: Antiviral / Direct-Acting Antiviral (DAA)
Indication: Chronic Hepatitis C Virus (HCV) Infection – Genotypes 1, 4, 5, and 6
Ledipasvir (90 mg) + Sofosbuvir (400 mg) is a fixed-dose combination antiviral therapy used for the treatment of chronic hepatitis C virus (HCV) infection. This combination is approved for use in adult and pediatric patients and is highly effective across multiple HCV genotypes, offering a simplified and well-tolerated oral regimen.
